Health Condition 1: A150- Tuberculosis of lung
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.New sputum positive cases 2.Non-diabetic (FBS 3.Not taking any other immunomodulator drugs.
Exclusion criteria
Exclusion criteria: 1. Immunocompromised states such as Chronic debilitating diseases, HIV-AIDS 2. Hb% 3. Any Drug resistant TB. 4. Impaired Liver or Renal function . 5. Respiratory Insufficiency/Hypoxia (peripheral oxygen saturation level 6. Pregnancy / Lactating mother.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Sputum conversion of new sputum positive non-diabetic pulmonary tuberculosis patients 2.Time taken for sputum conversionTimepoint: Every 15 days for a period of 2 months from initiation of therapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Effect of Metformin on: 1.Symptoms of Pulmonary TB- cough, fever, weight loss, breathlessness and fatigue. 2.Adverse effects in patients taking MET and ATT co-therapy Timepoint: Every 1 month after initiation of therapy. | — |
Countries
India
Contacts
Veer Surendra Sai Institute of Medical Sciences and Research